A study researched the relationship between TILs with response to neoadjuvant chemotherapy in breast cancer and reported that the pathologic complete response (pCR) rate was positively relevant to TILs in human HER2-positive and TNBC samples (12). The gene discussed is ERBB2; the disease is breast cancer.